The role of ferroptosis in osteoporosis: from pathogenic mechanisms to natural product-driven therapeutic innovations. [PDF]
Front Med (Lausanne)Zhu Y, Wu X, Peng X, He H, Hu Z, Xiao L.
europepmc +1 more source
Association Between Sclerostin and Sarcopenia-Related Functional Decline in Older Women. [PDF]
Diagnostics (Basel)Lee DG, Lee JH, Kong E.
europepmc +1 more source
The effects of combined calcium and vitamin D supplementation on bone mineral density and fracture risk in postmenopausal women with osteoporosis: a systematic review and meta-analysis of randomized controlled trials. [PDF]
BMC Musculoskelet DisordCong B, Zhang H.
europepmc +1 more source
Risk factors for secondary fractures in postmenopausal osteoporosis: A retrospective study. [PDF]
Medicine (Baltimore)Zhang H, Du Y, Hu L.
europepmc +1 more source
Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis. [PDF]
Turk J Med SciGündüz B, Kiliç Kan E, Atmaca A.
europepmc +1 more source
The effect of non-pharmacological interventions on bone health among patients with low bone mass: a systematic review and meta-analysis. [PDF]
Front Endocrinol (Lausanne)Na X +11 more
europepmc +1 more source
Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]
BMC Musculoskelet DisordZhang Y, Cui W, Hou L.
europepmc +1 more source
The effect of acupuncture-related therapies in animal model of postmenopausal osteoporosis: a meta-analysis and data mining approach. [PDF]
Front Endocrinol (Lausanne)Yu G, Gao Y, Song H, Chen G, Xu Y.
europepmc +1 more source
Related searches:
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
+9 more sources